Korea FilingsFull brief — $39

KyungdongPharm

경동제약(주) · KOSDAQ: 011040 · Pharmaceuticals and medicinal chemicals

Key facts

Korean name
경동제약(주)
Market / ticker
KOSDAQ · 011040
Industry
Pharmaceuticals and medicinal chemicals
Established
1976-02-12
Fiscal year ends
December
Website
www.kdpharma.co.kr
DART corp code
00101549
Latest revenue
₩196.3B (FY2025)

Items worth checking

medium
Decision to issue convertible / warrant / exchangeable bonds — the filing states whether new or treasury shares back it — filed 2025-12-16.

Financial summary

KRWFY2023FY2024FY2025
Revenue₩162.7B₩193.9B₩196.3B
Operating income−₩25.0B₩2.6B₩7.7B
Net income−₩20.7B₩5.4B₩8.5B
Total assets₩293.0B₩302.9B₩321.9B
Total liabilities₩64.5B₩82.5B₩93.0B
Total equity₩228.5B₩220.3B₩228.9B
Share capital₩15.7B₩15.7B₩15.7B

Consolidated statements · FY2025 operating margin 3.9% · liabilities to equity 41% · Annual report FY2025 (Korean original)

Auditor opinions

PeriodAuditorOpinion
Term 50 (current)한영회계법인Unqualified
Term 49 (prior)한영회계법인Unqualified
Term 48 (two years prior)한영회계법인Unqualified

Largest shareholder history

DateLargest shareholder (Korean)StakeCause (Korean)
2019년 09월 18일류기성수증

Recent filings

DateFilingOriginal
2026-08-31Large shareholding (5%+) reportDART
2026-08-27Amended: Share pledge agreement that may change the largest shareholderDART
2026-08-18Officer / major shareholder ownership reportDART
2026-08-14Half-year report (2026.06)DART
2026-07-14Officer / major shareholder ownership reportDART
2026-07-10Large shareholding (5%+) reportDART
2026-07-10Officer / major shareholder ownership reportDART
2026-07-06Amended: Share pledge agreement that may change the largest shareholderDART
2026-06-09Officer / major shareholder ownership reportDART
2026-05-14Quarterly report (2026.03)DART
2026-04-03Large shareholding (5%+) reportDART
2026-03-30Corporate value-up plan (voluntary)DART
2026-03-30Annual general meeting resultsDART
2026-03-20Annual report (2025.12)DART
2026-03-20Audit report submittedDART
2026-03-13Notice of shareholders meetingDART
2026-03-11Treasury share disposal results reportDART
2026-03-10Reason for holding meeting on peak AGM dateDART
2026-03-06Amended: Cash / in-kind dividend decisionDART
2026-03-05Material event report — Treasury share disposal decisionDART

Showing the 20 most recent of 37 filings. The full brief lists all of them.

Full brief on KyungdongPharm — $39 Get the full brief

For business customers. EU companies: enter your VAT number at checkout and no VAT is charged (reverse charge).

Other Korean companies in Pharmaceuticals and medicinal chemicals

Data generated 2026-09-16 from OpenDART.

This page summarizes public filings from DART, the official electronic disclosure system of Korea. It is not investment, credit or legal advice. Figures are shown in the currency the company reports in. Titles and labels are machine-translated and may contain errors — always check the linked original filing. Source: OpenDART, Financial Supervisory Service, Korea.